XJPX4480
Market cap750mUSD
Jan 17, Last price
3,610.00JPY
1D
-0.28%
1Q
-7.08%
IPO
195.18%
Name
Medley Inc
Chart & Performance
P/E
45.70
P/S
5.71
EPS
78.99
Div Yield, %
0.00%
Shrs. gr., 5y
3.41%
Rev. gr., 5y
47.58%
Revenues
20.53b
+44.74%
Net income
2.57b
+152.31%
CFO
3.87b
+92.30%
Earnings
Feb 12, 2025
Profile
Medley, Inc. operates platforms for recruitment and medical businesses in Japan. It operates through three segments: HR Platform Business, Medical Platform Business, and New Services. The company manages JobMedley, a human resource recruitment system for medical and healthcare, and related businesses; CLINICS Telemedicine, a telemedicine system for patients and medical institutions; CLINICS, a cloud medical support system; Pharms pharmacy window support systems; and MEDLEY, a medical information service for patients, as well as Kaigo-no Honne, a website to search nursing care facilities. It also conducts proof-of-concept testing for pharms. Medley, Inc. was incorporated in 2009 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||
Revenues | 20,532,000 44.74% | 14,185,000 30.57% | |||||
Cost of revenue | 17,896,000 | 12,711,000 | |||||
Unusual Expense (Income) | |||||||
NOPBT | 2,636,000 | 1,474,000 | |||||
NOPBT Margin | 12.84% | 10.39% | |||||
Operating Taxes | 1,230,000 | 502,000 | |||||
Tax Rate | 46.66% | 34.06% | |||||
NOPAT | 1,406,000 | 972,000 | |||||
Net income | 2,566,000 152.31% | 1,017,000 80.64% | |||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 101,000 | 104,000 | |||||
BB yield | -0.07% | -0.08% | |||||
| Debt | |||||||
Debt current | 731,000 | 772,000 | |||||
Long-term debt | 928,000 | 1,604,000 | |||||
Deferred revenue | |||||||
Other long-term liabilities | 234,000 | 191,000 | |||||
Net debt | (15,287,000) | (13,729,000) | |||||
| Cash flow | |||||||
Cash from operating activities | 3,871,000 | 2,013,000 | |||||
CAPEX | (403,000) | (378,000) | |||||
Cash from investing activities | (1,662,000) | (751,000) | |||||
Cash from financing activities | (1,218,000) | (927,000) | |||||
FCF | 1,180,000 | 849,755 | |||||
| Balance | |||||||
Cash | 15,354,000 | 14,422,000 | |||||
Long term investments | 1,592,000 | 1,683,000 | |||||
Excess cash | 15,919,400 | 15,395,750 | |||||
Stockholders' equity | 3,942,000 | 1,656,000 | |||||
Invested Capital | 15,587,000 | 15,772,000 | |||||
ROIC | 8.97% | 7.72% | |||||
ROCE | 13.23% | 8.26% | |||||
| EV | |||||||
Common stock shares outstanding | 32,673 | 32,663 | |||||
Price | 4,400.00 11.96% | 3,930.00 65.68% | |||||
Market cap | 143,762,181 11.99% | 128,365,775 64.81% | |||||
EV | 128,560,181 | 114,724,775 | |||||
EBITDA | 3,322,000 | 2,041,000 | |||||
EV/EBITDA | 38.70 | 56.21 | |||||
Interest | 11,000 | 11,000 | |||||
Interest/NOPBT | 0.42% | 0.75% | |||||